Ligand profile
105
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0891 — beta-lactamase SHV-24
Identifiers
Database identifiers and provenance.
- Ligand ID
105- PDB
1jwz- UniProt (similar protein)
P62593- Target protein
- VK055_0891
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 95.6
- −1 ≤ LogP ≤ 5 1.05
- MW ≤ 500 Da 294.5
- LogP ≤ 5 1.05
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 95.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
B(CNC(=O)c1c(onc1c2ccccc2Cl)C)(O)OB(CNC(=O)c1c(onc1c2ccccc2Cl)C)(O)O
InChI=1S/C12H12BClN2O4/c1-7-10(12(17)15-6-13(18)19)11(16-20-7)8-4-2-3-5-9(8)14/h2-5,18-19H,6H2,1H3,(H,15,17)InChI=1S/C12H12BClN2O4/c1-7-10(12(17)15-6-13(18)19)11(16-20-7)8-4-2-3-5-9(8)14/h2-5,18-19H,6H2,1H3,(H,15,17)
LSXNXXCBOPILJR-UHFFFAOYSA-NLSXNXXCBOPILJR-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00144' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 105 →
- PDB RCSB structure 1jwz →
- UniProt UniProt P62593 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “105”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0891.
PDB 43
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).